$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Drug carriers 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • A01N-061/00
출원번호 US-0210098 (2008-09-12)
등록번호 US8003621 (2011-08-08)
발명자 / 주소
  • Niitsu, Yoshiro
  • Yu, Lei
  • Liu, Jian
  • Zhao, Gang
  • Ma, Nianchun
  • Van, Sang
출원인 / 주소
  • Nitto Denko Corporation
대리인 / 주소
    Knobbe, Martens, Olson & Bear LLP
인용정보 피인용 횟수 : 8  인용 특허 : 224

초록

Compositions that can include a cationic polymeric carrier, targeting agent, and therapeutic agent are disclosed herein. The therapeutic agent may have a therapeutic activity such as inhibiting fibrosis within a target organ or tissue or inhibiting the growth of a cancer cell.

대표청구항

What is claimed is: 1. A therapeutic compositions comprising:A cationic polymeric carrier which comprises a recurring polyethylene glycol (PEG) unit; a recurring polyethyleneimine (PEI) unit; a targeting agent comprising a retinoid; and a recurring degradable unit, wherein the cationic polymeric car

이 특허에 인용된 특허 (224)

  1. Martin, Francis J.; Zalipsky, Samuel, 10139483Therapeutic liposome composition and method of preparation.
  2. Hauptmann,Randal; Eisenreich,Robert; Eschenfeldt,William; Khambatta,Zubin, 4-ketocarotenoids in flower petals.
  3. Hutchinson,John H.; Prasit,Petpiboon Peppi; Moran,Mark; Evans,Jillian F.; Zunic,Jasmine Eleanor; Stock,Nicholas Simon, 5-lipoxygenase-activating protein (FLAP) inhibitors.
  4. Piccariello, Thomas; Olon, Lawrence P.; Kirk, Randall J., Active agent delivery systems and methods for protecting and administering active agents.
  5. Freitag Ruth,CHX ; Garret-Flaudy Frederic,CHX, Affinity macroligands.
  6. Frankenberger,Marion; Maier,Konrad; Scheuch,Gerhard; Ziegler Heitbrock,Hans Werner, Agent for treating illnesses of the tracheobronchial tract, especially chronic obstructive pulmonary disease (COPD).
  7. Lele,Bhalchandra Shripad; Leroux,Jean Christophe, Amphiphilic diblock, triblock and star-block copolymers and their pharmaceutical compositions.
  8. Uhrich,Kathryn E.; Tian,Lu, Amphiphilic star-like macromolecules for drug delivery.
  9. Hunter William L.,CAX ; Machan Lindsay S.,CAX ; Arsenault A. Larry,CAX, Anti-angiogenic Compositions and methods for the treatment of arthritis.
  10. Hunter William L.,CAX ; Machan Lindsay S.,CAX ; Arsenault A. Larry,CAX, Anti-angiogenic compositions and methods of use.
  11. Hunter, William L.; Machan, Lindsay S.; Arsenault, A. Larry, Anti-angiogenic compositions and methods of use.
  12. Hunter, William L.; Machan, Lindsay S.; Arsenault, A. Larry, Anti-angiogenic compositions and methods of use.
  13. Sakamoto, Izumi; Takagi, Kunihiko, Anti-cancer device.
  14. Thorpe,Philip E.; Soares,M. Melina; He,Jin, Anti-viral treatment methods using phosphatidylethanolamine-binding peptide derivatives.
  15. Philip E. Thorpe ; Rolf A. Brekken, Antibody compositions for selectively inhibiting VEGF.
  16. Thorpe, Philip E.; Brekken, Rolf A., Antibody conjugate formulations for selectively inhibiting VEGF.
  17. Philip E. Thorpe ; Rolf A. Brekken, Antibody conjugate kits for selectively inhibiting VEGF.
  18. Thorpe, Philip E.; Brekken, Rolf A., Antibody methods for selectively inhibiting VEGF.
  19. Taylor Jennifer K. ; Cowsert Lex M., Antisense inhibition of fra-1 expression.
  20. Gaarde, William; Watt, Andrew T., Antisense modulation of connective tissue growth factor expression.
  21. Dobie,Kenneth W.; Koller,Erich, Antisense modulation of kinesin-like 1 expression.
  22. Dobie,Kenneth W.; Koller,Erich, Antisense modulation of kinesin-like 1 expression.
  23. Magnus Pfahl ; Xian-Ping Lu ; Darryl Rideout ; Hongyue Zhang, Apoptosis inducing adamantyl derivatives and their usage as anti-cancer agents, especially for cervical cancers and dysplasias.
  24. Hendry Philip,AUX ; McCall Maxine J.,AUX, Asymmetric hammerhead ribozymes.
  25. Friedman Doron,ILX ; Schwartz Joseph,ILX ; Amselem Shimon,ILX, Bioadhesive emulsion preparations for enhanced drug delivery.
  26. Dyer John C. ; Hird Bryn ; Wong Pui Kwan, Biodegradable and/or compostable polymers made from conjugated dienes such as isoprene and 2,3-dimethyl-1,3-butadiene.
  27. Ahn, Cheol Hee; Kim, Sung Wan, Biodegradable cationic copolymers of poly (alkylenimine) and poly (ethylene glycol) for the delivery of bioactive agents.
  28. Zhao,Gang; Fu,Xiaoli; Yu,Lei, Biodegradable cationic polymers.
  29. Gref Ruxandra (Nancy FRX) Minamitake Yoshiharu (Brookline MA) Langer Robert S. (Newton MA), Biodegradable injectable nanoparticles.
  30. Langer,Robert S.; Lynn,David M.; Putnam,David; Amiji,Mansoor M.; Anderson,Daniel G., Biodegradable poly(β-amino esters) and uses thereof.
  31. Lubnin, Alexander V.; Snow, George E.; Varn, Ronald D.; Anderle, Gary A., Breathable polyurethanes, blends, and articles.
  32. Thorpe,Philip E.; Ran,Sophia; Brekken,Rolf A., Cancer treatment kits comprising therapeutic conjugates that bind to aminophospholipids.
  33. Thorpe Philip E. ; Ran Sophia, Cancer treatment methods using therapeutic conjugates that bind to aminophospholipids.
  34. Peter M. Fischer GB; Shudong Wang GB; Nikolai Zhelev GB, Carrier based drug delivery system.
  35. Takei Yoshiyuki,JPX ; Maruyama Atsushi,JPX ; Akaike Toshihiro,JPX ; Kawano Sunao,JPX ; Okumura Shigetoshi,JPX ; Nogawa Masayuki,JPX ; Asayama Shoichiro,JPX, Carriers targettable to organ.
  36. Mahato, Ram I.; Han, Sang-Oh; Furgeson, Darin Y., Cationic lipopolymer as biocompatible gene delivery agent.
  37. Hanno V. J. Kolbe FR; Otmane Boussif FR; Thierry Delair FR; Laurent Veron FR, Cationic polymers, complexes associating said cationic polymers with therapeutically active substances comprising at least a negative charge, in particular nucleic acids, and their use in gene therap.
  38. Sagara, Kazuyoshi, Cellular targeting poly(ethylene glycol)-grafted polymeric gene carrier.
  39. Unger, Evan C., Charged lipids and uses for the same.
  40. Chen Feng-Jing ; Patel Mahesh V., Clear oil-containing pharmaceutical compositions.
  41. Riegel,Anna T.; Reiter,Ronald; Wellstein,Anton, Coactivators in the diagnosis and treatment of breast cancer.
  42. Fearnot Neal E. (West Lafayette IN) Kozma Thomas G. (West Lafayette IN) Ragheb Anthony O. (West Lafayette IN) Voorhees William D. (West Lafayette IN), Coated implantable medical device.
  43. Ragheb Anthony O. ; Bates Brian L. ; Fearnot Neal E. ; Kozma Thomas G. ; Voorhees ; III William D., Coated implantable medical device.
  44. Ragheb Anthony O. ; Bates Brian L. ; Fearnot Neal E. ; Kozma Thomas G. ; Voorhees ; III William D., Coated implantable medical device.
  45. Schottman,Thomas C.; Hennessey,Patrick M.; Gruening,Rainer, Coating composition for multiple hydrophilic applications.
  46. Hossainy, Syed F. A.; Wu, Steven Z.; Gada, Manish; Andreacchi, Anthony, Coating for implantable devices and a method of forming the same.
  47. Muller Marcel,CHX ; Geiger Thomas,DEX ; Altmann Karl-Heinz,CHX ; Fabbro Doriano,CHX ; Dean Nicholas M. ; Monia Brett ; Bennett Clarence Frank, Combination for treatment of proliferative diseases.
  48. Quang Lan Nguyen FR; Boudiaf Boussouira FR; Stephanie Prince FR; Paolo Giacomoni FR, Combination of a retinoid with a polyamine polymer.
  49. Thorpe, Philip E.; Ran, Sophia; Brekken, Rolf A., Combined cancer treatment methods using therapeutic conjugates that bind to aminophospholipids.
  50. Lemelson Jerome H. (85 Rector St. Metuchen NJ 08840), Composition and method for detecting and treating cancer.
  51. Hersh Theodore, Composition for relief of arthritis-induced symptoms.
  52. Wu YouNeng ; Youle Richard J., Composition of immunotoxins and retinoids and use thereof.
  53. Grinstaff Mark W. (Pasadena CA) Soon-Shiong Patrick (Los Angeles CA) Wong Michael (Champaign IL) Sandford Paul A. (Los Angeles CA) Suslick Kenneth S. (Champaign IL) Desai Neil P. (Los Angeles CA), Composition useful for in vivo delivery of biologics and methods employing same.
  54. Desai, Neil P.; Soon-Shiong, Patrick, Compositions and methods for administration of pharmacologically active compounds.
  55. Feng-Jing Chen ; Mahesh V. Patel, Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents.
  56. Tolentino,Michael J.; Reich,Samuel Jotham, Compositions and methods for siRNA inhibition of angiogenesis.
  57. Patt, Leonard M., Compositions and methods for treatment of rosacea.
  58. Falcon Juan, Compositions and methods of treating cancer with tannin complexes.
  59. Gerber,Hanspeter; Bunting,Stuart; Liang,Xiao Huan, Compositions and methods of using angiopoietin-like 4 protein antibody.
  60. Johnson,Jeffrey D.; Zhou,Yun Ping; Marlen,Kimberly, Compositions and methods of using apoptosis signaling kinase related kinase (ASKRK).
  61. Johnson,Jeffrey D.; Zhou,Yun Ping; Marlen,Kimberly, Compositions and methods of using apoptosis signaling kinase related kinase (ASKRK).
  62. Glick,Gary D., Compositions and methods relating to F1F0-ATPase inhibitors and targets thereof.
  63. Lewis,David L.; Hagstrom,James E.; Herweijer,Hans; Loomis,Aaron G.; Monahan,Sean D.; Wolff,Jon A., Compositions and processes using siRNA, amphipathic compounds and polycations.
  64. Ian C. Bathurst ; Matthew W. Foehr ; J. Graham Goddard ; Samiul R. Umansky ; John D. Bradley ; Donald H. Picker, Compositions containing lysophosphotidic acids which inhibit apoptosis and uses thereof.
  65. Kirby,Kenneth B; Pettersson,Berno, Compositions for rapid and non-irritating transdermal delivery of pharmaceutically active agents and methods for formulating such compositions and delivery thereof.
  66. Bischoff, Rainer; Kolbe, Hanno; Schughart, Klaus, Compositions for the delivery of polynucleotides to cells.
  67. Bloom Roberta C. (Huntington CT) Deckner George E. (Cincinnati OH), Compositions for topical delivery of drugs comprising a mixture of high and low HLB surfactants and alkoxylated ether.
  68. Cooper, Eugene R.; Ruddy, Stephen B., Compositions having a combination of immediate release and controlled release characteristics.
  69. Sipos Tibor (Lebanon NJ), Compositions of gastric acid-resistant microspheres containing buffered bile acids.
  70. Glick,Gary D., Compositions relating to novel compounds and targets thereof.
  71. Sokoloff,Alexander V.; Wong,So; Wolff,Jon A.; Monahan,Sean D.; Ludtke,James; Higgs,Lori; Wakefield,Darren; Sebesty챕n,Magdolna G., Compounds for targeting hepatocytes in vivo.
  72. Byun, Young-Ro; Kim, Sang-Yoon; Kim, Sun-Hee; Choi, Yong-Doo; Han, In-Suk; Lee, Kwang-Sun; Kim, Chul-Hee, Controlled drug release system of retinoic acid.
  73. Brem Henry (Lutherville MD) Langer Robert S. (Newton MA) Domb Abraham J. (Efrat ILX), Controlled local delivery of chemotherapeutic agents for treating solid tumors.
  74. Milan F. Sojka ; Ralph Spindler, Controlled release compositions and method.
  75. Reed,John C.; Zhang,Xiao kun; Guo,Bin; Lin,Bingzhen; Kolluri,Siva Kumar, Conversion of apoptotic proteins.
  76. Reed,John C.; Zhang,Xiao kun; Guo,Bin; Lin,Bingzhen; Kolluri,Siva Kumar, Conversion of apoptotic proteins.
  77. Morancais Jean-Luc (Ozoir-La-Ferriere FRX) Philippe Michel (Antony FRX), Cosmetic pharmaceutical or foodstuff composition comprising an aqueous dispersion of lipidic vesicles.
  78. Gee,Kyle R.; Martin,Vladimir V., Crown ether derivatives.
  79. Martin, Vladimir V.; Gee, Kyle R.; Haugland, Richard P.; Diwu, Zhenjun, Crown ether derivatives.
  80. Wood Louis L. (Rockville MD) Calton Gary J. (Elkridge MD), Cryogel bandage containing therapeutic agent.
  81. Wood Louis L. (Rockville MD) Calton Gary J. (Elkridge MD), Cryogel oral pharmaceutical composition containing therapeutic agent.
  82. Loftsson Thorsteinn (Reykjavik ISX), Cyclodextrin complexation.
  83. Cheng,Jianjun; Davis,Mark E.; Khin,Kay T., Cyclodextrin-based polymers for therapeutics delivery.
  84. Schacht Etienne H,BEX ; Seymour Leonard C W,GBX ; Ulbrich Karel,CZX, Delivery of nucleic acid materials.
  85. Goldenberg David M. (Short Hills NJ), Detection and therapy of lesions with biotin/avidin conjugates.
  86. Griffiths Gary L. (Morristown NJ), Detection and therapy of lesions with biotin/avidin polymer conjugates.
  87. Klaveness, Jo; Rongved, P.ang.l; H.o slashed.gset, Anders; Tolleshaug, Helge; Cuthbertson, Alan; Godal, Aslak; Hoff, Lars; Gogstad, Geir; Bryn, Klaus; N.ae butted.vestad, Anne; L.o slashed.vhaug, Dag, Diagnostic/therapeutic agents.
  88. Tkes Zoltn A. (Los Angeles CA) Rogers Kathryn E. (Pasadena CA) Rembaum Alan (Pasadena CA), Drug delivery by polymeric carriers.
  89. Yang,Victor C.; Park,Yoon Jeong; Liang,Junfeng, Drug delivery compositions.
  90. Pinchuk, Leonard; Nott, Sepideh; Schwarz, Marlene; Kamath, Kalpana, Drug delivery compositions and medical devices containing block copolymer.
  91. Beer-Romero Peggy L. ; Draetta Giulio ; Rolfe Mark, E6AP antisense constructs and methods of use.
  92. De Groot,Franciscus Marinus Hendrikus; Beusker,Patrick Henry; Scheeren,Johannes Wilhelm; De Vos,Dick; Van Berkom,Leonardus Wilhelmus Adriaan; Busscher,Guuske Frederike; Seelen,Antoinette Eugenie; Koe, Elongated and multiple spacers in activatible prodrugs.
  93. Uhlmann Eugen,DEX ; Engels Joachim,DEX ; Scherr Michaela,DEX ; Ganser Arnold,DEX, Enzymatic RNA molecules that cleave mutant N-RAS.
  94. Burton Graham (Orleans CAX) Daroszewski Janusz (Gloucester CAX) Phipps Jenny (Ottawa CAX), Extensively oxidized derivatives of carotenoids, retinoids and related conjugated polyenes useful as non-toxic cell-diff.
  95. Pershadsingh Harrihar A. ; Avery Mitchell A., Flavonoid derivatives.
  96. Mehta Kapil ; Perez-Soler Roman ; Lopez-Berestein Gabriel ; Lenk Robert ; Hayman Alan C., Formulation and use of carotenoids in treatment of cancer.
  97. Mehta Kapil ; Perez-Soler Roman ; Lopez-Berestein Gabriel ; Lenk Robert P. ; Hayman ; deceased Alan C., Formulation and use of carotenoids in treatment of cancer.
  98. Crouzet, Jo?l; Pitard, Bruno, Formulation of stabilized cationic transfection agent(s) /nucleic acid particles.
  99. Jeong,Seo Young; Kwon,Ick Chan; Chung,Hesson, Formulation solubilizing water-insoluble agents and preparation method thereof.
  100. Oh,Seungjoon; Lee,Minhyung; Ko,Kyungsoo, GLP-1 gene delivery for the treatment of type 2 diabetes.
  101. Unger Evan C. ; Matsunaga Terry O. ; Yellowhair David, Gas and gaseous precursor filled microspheres as topical and subcutaneous delivery vehicles.
  102. Wang,Shaomeng; Chen,Jiangyong, Gossypol co-crystals and the use thereof.
  103. Park Jong Sang,KRX ; Choi Young-Hun,KRX ; Liu Feng, Hepatocyte targeting polyethylene glyco-grafted poly-L-lysine polymeric gene carrier.
  104. Ignatious,Francis, Heterofunctional copolymers of glycerol and polyethylene glycol, their conjugates and compositions.
  105. Ramanathan,Chandra S.; Feder,John N., Human G-protein coupled receptor variant of HM74, HGPRBMY74.
  106. Liu,Qiang Yuan; Nambi,Ponnal, Human LXRα variants.
  107. Zarif, Leila; Jin, Tuo; Segarra, Ignacio; Mannino, Raphael J., Hydrogel-isolated cochleate formulations, process of preparation and their use for the delivery of biologically relevant molecules.
  108. Uhrich Kathryn E., Hyperbranched polymeric micelles for encapsulation and delivery of hydrophobic molecules.
  109. Orest Olejnik ; Patrick M. Hughes ; John S. Kent, Implant device with a retinoid for improved biocompatibility.
  110. Kung,Hsiang Fu; He,Ming Liang, Inhibition of hepatitis B virus (HBV) replication by RNA interference.
  111. Sakamoto Izumi (Kyoto JPX) Takagi Kunihiko (Kyoto JPX), Injector filled with an anti-cancer composition.
  112. Mandeville ; III W. Harry ; Holmes-Farley Stephen Randall ; Neenan Thomas X. ; Whitesides George M., Interpenetrating polymer networks for sequestration of bile acids.
  113. Wolff,Jon A.; Budker,Vladimir G.; Hagstrom,James E.; Hegge,Julia; Herweijer,Hans, Intravascular delivery of nucleic acid.
  114. Demo,Susan; Hitoshi,Yasumichi; Pearsall,Denise, LETM1: modulators of cellular proliferation.
  115. Tamura, Gakuzo; Ando, Kunio; Magae, Junji; Uchida, Takafumi, Ligands of nuclear receptor.
  116. Davis, Mark E.; Gonzalez, Hector; Hwang, Suzie (Sue Jean), Linear cyclodextrin copolymers.
  117. Davis, Mark E.; Gonzalez, Hector; Hwang, Suzie (Sue Jean), Linear cyclodextrin copolymers.
  118. Davis,Mark E.; Gonzalez,Hector; Hwang,Suzie Sue Jean, Linear cyclodextrin copolymers.
  119. Herscovici, Jean; Scherman, Daniel; Tranchant, Isabelle; Mignet, Nathalie; Girard, Christian, Lipid derivatives of polythiourea.
  120. Chen,Tongqian; Vargeese,Chandra; Vagle,Kurt; Wang,Weimin; Zhang,Ye, Lipid nanoparticle based compositions and methods for the delivery of biologically active molecules.
  121. Fernandez Julio M. ; Knudson Mark B., Lipid-coated condensed-phase microparticle composition.
  122. Yen Shau-Fong (Atlanta GA) Reed Kenneth W. (Lawrenceville GA), Liquid ophthalmic sustained release delivery system.
  123. Firestone Raymond Armand ; Dubowchik Gene Michael, Lysosomal enzyme-cleavable antitumor drug conjugates.
  124. Ellingsen,Jan Eirik; Lyngstadaas,Staale Petter, Medical prosthetic devices having improved biocompatibility.
  125. Labhasetwar,Vinod D.; Reddy,Maram K., Method and composition for inhibiting reperfusion injury in the brain.
  126. Ortlieb, Thomas E.; Read, Walter, Method and system for adaptive sampling testing of assemblies.
  127. Evan C. Unger, Method for delivering bioactive agents using cochleates.
  128. Mislick Kimberly Ann, Method for increasing or decreasing transfection efficiency.
  129. Fernandez Julio M. ; Knudson Mark B., Method of delivering a lipid-coated condensed-phase microparticle composition.
  130. Davis,Mark E.; Gonzalez,Hector; Hwang,Suzie (Sue Jean), Method of preparing a supramolecular complex containing a therapeutic agent and a multi-dimensional polymer network.
  131. Bologna William J. (New York NY) Levine Howard L. (Oceanside NY), Method of progesterone delivery and affect thereof.
  132. Perez,Omar D.; Nolan,Garry P., Methods and compositions for detecting receptor-ligand interactions in single cells.
  133. D'Amato, Robert, Methods and compositions for inhibition of angiogenesis with EM-138.
  134. Johnson,Jeffrey D.; Zhou,Yun Ping, Methods and compositions for treating and diagnosing diabetes and related diseases involving beta-TRP.
  135. Elledge,Stephen J.; Cortez,David K.; Zou,Lee, Methods and compositions in checkpoint signaling.
  136. Dmitrovsky Ethan ; Warrell ; Jr. Raymond P. ; Miller ; Jr. Wilson H. ; Frankel Stanley, Methods for detection of acute promyelocytic leukemia (APL).
  137. Brys,Reginald; Vandeghinste,Nick; Tomme,Peter Herwig Maria, Methods for identification, and compounds useful for the treatment of degenerative & inflammatory diseases.
  138. Grinstaff Mark W. (Pasadena CA) Soon-Shiong Patrick (Los Angeles CA) Wong Michael (Champaign IL) Sandford Paul A. (Los Angeles CA) Suslick Kenneth S. (Champaign IL) Desai Neil P. (Los Angeles CA), Methods for the preparation of blood substitutes for in vivo delivery.
  139. Grinstaff Mark W. (Pasadena CA) Soon-Shiong Patrick (Los Angeles CA) Wong Michael (Champaign IL) Sandford Paul A. (Los Angeles CA) Suslick Kenneth S. (Champaign IL) Desai Neil P. (Los Angeles CA), Methods for the preparation of nucleic acids for in vivo delivery.
  140. Julius,David; McKemy,David D.; Neuhausser,Werner M., Methods of modulating cold sensory perception.
  141. Detmar, Michael J.; Yano, Kiichiro, Methods of preventing UVB-induced skin damage.
  142. Sutherland,May S. Kung; Geoghegan,James C.; Latham,John; Yu,Changpu, Methods to increase or decrease bone density.
  143. Zhao, Xuan, Multi-arm block copolymers as drug delivery vehicles.
  144. Zhao,Xuan, Multi-arm block copolymers as drug delivery vehicles.
  145. Zhao,Xuan; Ren,Zhongxu; Emoto,Kazunori, Multi-arm polypeptide-poly (ethylene glycol) block copolymers as drug delivery vehicles.
  146. Beihoffer Thomas W. ; Mitchell Michael A., Multicomponent superabsorbent gel particles.
  147. James R. Baker, Jr. ; Donald A. Tomalia, Multifunctional nanodevice platform.
  148. Hovey,Douglas; Pruitt,John; Ryde,Tuula, Nanoparticulate megestrol formulations.
  149. Gustow,Evan; Ryde,Tuula; Cooper,Eugene R., Nanoparticulate topiramate formulations.
  150. Garvey,David S., Nitrosated and nitrosylated nebivolol and its metabolites, compositions and methods of use.
  151. Garvey, David S.; Letts, L. Gordon; Lin, Chia-En; Richardson, Stewart K.; Wang, Tiansheng, Nitrosated and nitrosylated taxanes, compositions and methods of use.
  152. Meadows David L. (Mission Viejo CA), Nonaqueous fluorinated drug delivery vehicle suspensions.
  153. Behr Jean-Paul,FRX ; Demeneix Barbara,FRX ; Lezoualch Franck,FRX ; Mergny Mojgan,FRX ; Scherman Daniel,FRX ; Boussif Otmane,FRX, Nucleic acid containing composition, preparation and uses of same.
  154. Scherman Daniel,FRX ; Byk Gerardo,FRX ; Schwartz Bertrand,FRX, Nucleic acid-containing composition, preparation and use thereof.
  155. Kanda S. Ramasamy ; Guangyi Wang ; Johnson Lau, Nucleoside compounds.
  156. Warren, Stephen, Nucleotide-based prodrugs.
  157. Burton,Graham; Daroszewski,Janusz; Phipps,Jenny; Arya,Prabhat, Oxidized carotenoid fractions and ketoaldehyde useful as cell-differentiation inducers, cytostatic agents, and anti-tumor agents.
  158. Sullivan Sean (Boulder CO), Permeability enhancers for negatively charged polynucleotides.
  159. Leigh, Steven; Leigh, Mathew L. S., Pharmaceutical compositions and their use.
  160. Tomic Dobrivoje (11 ; Dell\Oro Street Caldaro (Bolzano) ITX), Pharmaceutical compositions for the treatment of diabetes and of hepatic diseases and malfunctions.
  161. Lyle M. Bowman ; Santosh Kumar Chandrasekaran ; Rajesh Patel ; Hoa Vinh Vo, Plasticized bioerodible controlled delivery system.
  162. Papaioannou, Dionysios; Drainas, Dionysios; Tsambaos, Dionysios, Polyamine conjugates with acidic retinoids and preparation thereof.
  163. Rozema,David B.; Budker,Vladimir G.; Hagstrom,James E.; Trubetskoy,Vladimir; Wolff,Jon A.; Monahan,Sean D.; Slattum,Paul M., Polyampholytes for delivering polyions to a cell.
  164. Wang,Laixin, Polycationic water soluble copolymer and method for transferring polyanionic macromolecules across biological barriers.
  165. Park Jong Sang,KRX ; Choi Young Hun,KRX ; Kim Sung Wan, Polyester analogue of poly-L-lysine as a soluble, biodegradable gene delivery carrier.
  166. Summerton James E. ; Weller Dwight D., Polymer composition for delivering substances in living organisms.
  167. Koyama Yoshiyuki (Noda JPX) Kojima Shuji (Kashiwa JPX) Miyazaki Tsuyoshi (Tsukuba JPX) Suginaka Akinori (Chigasaki JPX) Matsumoto Takeo (Tsukuba JPX) Murata Yoshishige (Tsukuba JPX), Polymer-drug conjugate and a method of producing it.
  168. Chen Hongming ; Langer Robert S., Polymerized liposomes targeted to M cells and useful for oral or mucosal drug delivery.
  169. Ramanathan,Chandra S.; Feder,John N., Polynucleotide encoding a novel human G-protein coupled receptor variant of HM74, HGPRBMY74.
  170. Lee,Ning; Chen,Jian; Wu,Shujian; Blanar,Michael A.; Levesque,Paul C.; Sun,Lucy, Polynucleotides encoding variants of the TRP channel family member, LTRPC3.
  171. Krasnoperov,Valery; Zozulya,Sergey; Kertesz,Nathalie; Reddy,Ramachandra; Gill,Parkash, Polypeptide compounds for inhibiting angiogenesis and tumor growth.
  172. Gould Francis E. (Princeton NJ), Polyurethane polymers characterized by lactone groups and hydroxyl groups in the polymer backbone.
  173. Straub, Julie; Bernstein, Howard; Chickering, III, Donald E.; Khattak, Sarwat; Randall, Greg, Porous drug matrices and methods of manufacture thereof.
  174. DeLuca Patrick P. (Lexington KY) Kanke Motoko (Fukuyama JPX) Sato Toyomi (Tokyo CA JPX) Schroeder Hans G. (Encinitas CA), Porous microspheres for drug delivery and methods for making same.
  175. Yoo Seo Hong, Preparation of aqueous clear solution dosage forms with bile acids.
  176. Trubetskoy, Vladimir S.; Wolff, Jon A.; Hagstrom, James E.; Budker, Vladimir G.; Wong, So Chun; Klein, Jason, Process for generating multilayered particles.
  177. Trubetskoy,Vladimir; Wolff,Jon A.; Hagstrom,James E.; Budker,Vladimir G.; Wong,So Chun; Klein,Jason, Process for generating multilayered particles.
  178. Gilbert, Carl W.; McGowan, Eleanor B.; Black, Kirby S.; Harper, T. Gregory P., Prodrugs via acylation with cinnamate.
  179. Deckers, Harm M.; Van Rooijen, Gijs; Boothe, Joseph; Goll, Janis; Moloney, Maurice M., Products for topical applications comprising oil bodies.
  180. Swaisgood Harold E. ; Wang Qiwu ; Allen Jonathan C., Protein ingredient for carrying lipophilic nutrients.
  181. Desai Neil P. ; Tao Chunlin ; Yang Andrew ; Louie Leslie ; Zheng Tianli ; Yao Zhiwen ; Soon-Shiong Patrick ; Magdassi Shlomo,ILX, Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof.
  182. McCray,Paul B.; Davidson,Beverly L.; Fischer,Anthony J.; Jia,Hong P.; Donovan,Maureen D.; Sinn,Patrick L.; Behlke,Mark Aaron, RNA interference in respiratory epitheial cells.
  183. Heidenreich,Olaf; Vornlocher,Hans Peter; Hadwiger,Philipp, RNAi modulation of MLL-AF4 and uses thereof.
  184. Esenaliev Rinat O., Radiation and nanoparticles for enhancement of drug delivery in solid tumors.
  185. Bollag Werner (Basel CHX) Mayer Hans J. (Fllinsdorf CHX) Wyss Pierre-Charles (Muttenz CHX), Retinoid carbohydrates.
  186. Rodgers Kathleen E. (Long Beach CA) Dizerega Gere S. (Pasadena CA), Retinoid-based compositions and method for preventing adhesion formation using the same.
  187. Gozzini Luigia,ITX ; Muttoni Monica,ITX, Selectively functionalizable desdendrimers.
  188. Erdelmeir,Ir��ne; Michel,Jean Claude; Moutet,Marc; Yadan,Jean Claude, Selenohydroxy acids and their derivatives, applications in nutrition, cosmetics and pharmaceutics.
  189. Nunes,Joseph J.; Milne,Jill; Bemis,Jean; Xie,Roger; Vu,Chi B.; Ng,Pui Yee; Disch,Jeremy S., Sirtuin modulating compounds.
  190. Wadstein, Jan, Skin cream composition.
  191. Patel Mahesh V. ; Chen Feng-Jing, Solid carriers for improved delivery of active ingredients in pharmaceutical compositions.
  192. Patel, Mahesh V.; Chen, Feng-Jing, Solid carriers for improved delivery of active ingredients in pharmaceutical compositions.
  193. Patel, Mahesh V.; Chen, Feng-Jing, Solid carriers for improved delivery of hydrophobic active ingredients in pharmaceutical compositions.
  194. Westesen Kirsten,DEX ; Siekmann Britta,DEX, Solid lipid particles, particles of bioactive agents and methods for the manufacture and use thereof.
  195. Truong Vu L. ; August Thomas ; Leong Kam W., Solid microparticles for gene delivery.
  196. Ishii, Naoki; Togawa, Hideyuki, Stent.
  197. Ishii,Naoki, Stent and method of manufacturing stent.
  198. Olejnik Orest ; Hughes Patrick M. ; Kent John S., Sterile bioerodible implant device with a retinoid for improved biocompatability.
  199. Ailhaud Gerard,FRX ; Grimaldi Paul,FRX ; Safonova Irina,FRX ; Shroot Braham,FRX ; Reichert Uwe,FRX, Stimulating the differentiation of preadipocytic cells and therapies based thereon.
  200. Roth Laurence A. ; Herman Stephen Jack, Targeted delivery via biodegradable polymers.
  201. Bressi Jerome C. ; Douglass ; III James G. ; Seligson Allen ; Sovak Milos, Taxoids.
  202. Yang,Yi Yan; Soppimath,Kumaresh, Temperature and pH sensitive copolymers.
  203. Unger Evan C. ; Fritz Thomas A. ; Matsunaga Terry ; Ramaswami VaradaRajan ; Yellowhair David ; Wu Guanli, Therapeutic drug delivery systems.
  204. Martin Francis J. ; Zalipsky Samuel ; Huang Shi Kun, Therapeutic liposome composition and method.
  205. Martin, Francis J.; Zalipsky, Samuel; Huang, Shi Kun, Therapeutic liposome composition and method.
  206. Allen,Theresa M.; Uster,Paul; Martin,Francis J.; Zalipsky,Samuel, Therapeutic liposome composition and method of preparation.
  207. Morris,David W.; Malandro,Marc S.; Lai,Albert; Tse,Christin; Fattaey,Ali, Therapeutic targets in cancer.
  208. Neis,Arnold; Neis,Robert; Whittemore,Jerry, Topical cosmetic compositions containing alpha arbutin.
  209. Dow, Gordon J.; Lathrop, Robert W.; Dow, Debra A., Topical gel delivery system.
  210. Byk, Gerardo; Dubertret, Catherine; Pitard, Bruno; Scherman, Daniel, Transfecting compounds which are sensitive to reducing conditions, pharmaceutical compositions containing them and their applications.
  211. Kun,Ernest; Mendeleyev,Jerome; Basbaurn,Carol; Lemjabbar Alaoui,Hassan; Ossovskaya,Valeria, Treatment of cancer.
  212. Friedman,Scott; Albanis,Efsevia, Treatment of hepatic fibrosis with imatinib mesylate.
  213. Collingwood,Trevor, Treatment of neuropathic pain with zinc finger proteins.
  214. Patel Mahesh V. ; Chen Feng-Jing, Triglyceride-free compositions and methods for enhanced absorption of hydrophilic therapeutic agents.
  215. Patel Mahesh V. ; Chen Feng-Jing, Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents.
  216. Chun Li ; Sidney Wallace ; Dong-Fang Yu ; David J. Yang, Water soluble paclitaxel derivatives.
  217. Li, Chun; Wallace, Sidney; Yu, Dong-Fang; Yang, David, Water soluble paclitaxel derivatives.
  218. Li, Chun; Wallace, Sidney; Yu, Dong-Fang; Yang, David, Water soluble paclitaxel derivatives.
  219. Li,Chun; Wallace,Sidney; Yu,Dong Fang; Yang,David J., Water soluble paclitaxel derivatives.
  220. Li Chun ; Wallace Sidney ; Yu Dong-Fang ; Yang David J., Water soluble paclitaxel prodrugs.
  221. Li Chun ; Wallace Sidney ; Yu Dong-Fang ; Yang David J., Water soluble paclitaxel prodrugs.
  222. Desai Neil P. (Los Angeles CA) Soon-Shiong P. (Los Angeles CA) Sandford Paul A. (Los Angeles CA), Water-soluble polymeric carriers for drug delivery.
  223. Szankasi,Philippe; Mauck,Kimberly; Wettstein,Daniel Albert, Zinc finger proteins.
  224. Sant,Vinayak; Leroux,Jean Christophe, pH-sensitive block copolymers for pharmaceutical compositions.

이 특허를 인용한 특허 (8)

  1. Niitsu, Yoshiro, Agent for treating myelofibrosis.
  2. Zhao, Gang; Fu, Xiaoli; Yu, Lei, Biodegradable cationic polymers.
  3. Niitsu, Yoshiro; Payne, Joseph E.; Gaudette, John A.; Hou, Zheng; Knopov, Victor; Witte, Richard P.; Ahmadian, Mohammad; Perelman, Loren A.; Tanaka, Yasunobu; Akopian, Violetta, Compounds for targeting drug delivery and enhancing siRNA activity.
  4. Niitsu, Yoshiro; Kato, Junji; Sato, Yasushi, Drug carrier and drug carrier kit for inhibiting fibrosis.
  5. Niitsu, Yoshiro; Kato, Junji; Sato, Yasushi, Drug carrier and drug carrier kit for inhibiting fibrosis.
  6. Cao, Xiande; Liu, Jian; Kuo, An-yu, Methods, systems, and articles of manufacture for implementing electronic designs with a pseudo-3D analysis mechanism.
  7. Niitsu, Yoshiro; Takimoto, Rishu, Targeting agent for cancer cell or cancer-associated fibroblast.
  8. Niitsu, Yoshiro; Takimoto, Rishu; Minomi, Kenjiro; Miyazaki, Miyono; Kajiwara, Keiko; Tanaka, Yasunobu, Therapeutic agent for pulmonary fibrosis.
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로